Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Ackermann

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 15, 2005
Age of uptake of early cancer detection facilities by low-risk and high-risk patients with familial breast and ovarian cancerMichael Patrick Lux, Sven Ackermann, Mayada R Bani, et al.
Geburtshilfe Und Frauenheilkunde|April 6, 2023
Gestational and Non-gestational Trophoblastic Neoplasia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 032/049, April 2022)Clemens Tempfer, Lars-Christian Horn, Sven Ackermann, et al.
Breast Cancer Research and Treatment|June 14, 2024
The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancerChristian Jackisch, Louiza Anastasiadou, Sebastian Aulmann, et al.
Gynecologic Oncology|March 15, 2024
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancerPaul Gass, Falk C Thiel, Lothar Häberle, et al.
Journal of the National Cancer Institute|April 21, 2005
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trialPierluigi Benedetti Panici, Angelo Maggioni, Neville Hacker, et al.
Geburtshilfe Und Frauenheilkunde|October 29, 2019
Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Geburtshilfe Und Frauenheilkunde|December 5, 2022
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Geburtshilfe Und Frauenheilkunde|November 5, 2019
Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)Hans-Georg Schnürch, Sven Ackermann, Celine D Alt-Radtke, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 15, 2005
Age of uptake of early cancer detection facilities by low-risk and high-risk patients with familial breast and ovarian cancerMichael Patrick Lux, Sven Ackermann, Mayada R Bani, et al.
Geburtshilfe Und Frauenheilkunde|April 6, 2023
Gestational and Non-gestational Trophoblastic Neoplasia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 032/049, April 2022)Clemens Tempfer, Lars-Christian Horn, Sven Ackermann, et al.
Breast Cancer Research and Treatment|June 14, 2024
The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancerChristian Jackisch, Louiza Anastasiadou, Sebastian Aulmann, et al.
Gynecologic Oncology|March 15, 2024
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancerPaul Gass, Falk C Thiel, Lothar Häberle, et al.
Journal of the National Cancer Institute|April 21, 2005
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trialPierluigi Benedetti Panici, Angelo Maggioni, Neville Hacker, et al.
Geburtshilfe Und Frauenheilkunde|October 29, 2019
Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Geburtshilfe Und Frauenheilkunde|December 5, 2022
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Geburtshilfe Und Frauenheilkunde|November 5, 2019
Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)Hans-Georg Schnürch, Sven Ackermann, Celine D Alt-Radtke, et al.
Pageof 2